CMA issues charges in second pay-for-delay case

Janith Aranze

03 March 2017

CMA issues charges in second pay-for-delay case

iStock/DanielAzocar

The UK’s competition authority has accused two pharmaceutical companies of entering anticompetitive agreements that boosted prices the country’s National Health Service paid for  anti-inflammatory drug hydrocortisone